Optimizing Metabolic Health with Precision Insights from Advanced Microbiome Testing
Sponsored by:
Recent advances in research have uncovered the critical role of the gastrointestinal microbiome in influencing metabolic health. In this presentation, practitioners will learn about some of the most important – and surprising – ways in which the microbiome impacts various metabolic processes, especially via key microbial products like short-chain fatty acids and bile acids.
Join us on March 26 at 2 PM ET as Tom Fabian, PhD, CNTP, explores how advanced microbiome testing—using GI-MAP® and the soon-to-be-available StoolOMX™ Add-On panel—can pinpoint microbial imbalances linked to metabolic imbalances, as well as conditions such as:
- Metabolic syndrome
- Obesity
- Insulin resistance
What is StoolOMX™?
StoolOMX™, coming soon as an add-on to GI-MAP®, is a comprehensive bile acid and short-chain fatty acid stool test that provides deeper insights into:
- IBS & IBD
- Motility disorders
- Microbiome-driven metabolic imbalances
Be among the first to learn how pairing GI-MAP® with StoolOMX™ can enhance clinical insights and help you create more precise, targeted treatment strategies for your patients!
Speaker
Tom Fabian, PhD, CNTP
Tom is a clinical laboratory consultant for Diagnostic Solutions Laboratory. He is a translational science expert, functional nutrition practitioner, educator, and speaker. He is a former biomedical research scientist with deep expertise in the role of the human microbiome in health, chronic disease, and aging. As a leading expert in translational applications of microbiome research in functional medicine and integrative health settings, Tom’s primary focus is on providing educational resources and consulting services for practitioners, and consulting and advisory services for clinical testing laboratories. On a limited basis, he also works with individual clients to improve gastrointestinal health and optimize health span.
SHARE